StockData
QIAGEN N.V. logo

QIAGEN N.V. (QGEN) stock

QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 20, 2026Score 10/30
$46.55+0.42 (+0.91%)

Close on Oct 19, 2026Market cap –P/E 24.0Yield 0.54%

Qiagen free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was $453.28M, down 10.5% from the year before. Over ten years it grew 7.5% a year on average. The highest annual figure on record is $586.04M in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$453.28M-10.5%
FY2024Dec 31, 2024$506.38M+63.5%
FY2023Dec 31, 2023$309.75M-47.1%
FY2022Dec 31, 2022$586.04M+30.5%
FY2021Dec 31, 2021$449.10M+38.2%
FY2020Dec 31, 2020$325.02M+52.7%
FY2019Dec 31, 2019$212.89M-14.7%
FY2018Dec 31, 2018$249.72M+27.0%
FY2017Dec 31, 2017$196.70M-26.3%
FY2016Dec 31, 2016$267.07M+21.5%
FY2015Dec 31, 2015$219.72M+9.1%
FY2014Dec 31, 2014$201.37M+15.4%
FY2013Dec 31, 2013$174.49M+22.1%
FY2012Dec 31, 2012$142.88M-9.6%
FY2011Dec 31, 2011$157.97M-7.7%
FY2010Dec 31, 2010$171.09M+3.8%
FY2009Dec 31, 2009$164.82M+23.4%
FY2008Dec 31, 2008$133.55M–

More Qiagen figures

See a number that looks wrong?